FDA Adverse Event Injury Summary report: N

STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT

MDR report key: 14112254 · Received April 14, 2022

Report

Report Number
9617229-2022-05854
Event Type
Injury
Date Received
April 14, 2022
Date of Event
July 7, 2021
Report Date
October 11, 2022
Manufacturer
ALLERGAN (COSTA RICA)
Product Code
FTR
UDI-DI
05060191601108
PMA / PMN Number
P040046
Removal / Correction Number
2011068-7/2/19-001-R
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

(B)(4). A DEVICE HISTORY RECORD IS NOT AVAILABLE DUE TO INSUFFICIENT DEVICE DATA. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THE REASON FOR REOPERATION IS: "A DIAGNOSIS OF BIA-ALCL," "INTRA AND EXTRACAPSULAR RUPTURE," ¿SIGNIFICANT EFFUSION,¿ AND "A MASS 40 MM TUMOR.¿

Additional Manufacturer Narrative · 0

A REVIEW OF THE DEVICE HISTORY RECORD HAS BEEN INITIATED. IF ANY NEW, CHANGED OR CORRECTED INFORMATION IS NOTED, A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED.

Description of Event or Problem · 0

PHYSICIAN REPORTED RIGHT SIDE VIA REGULATORY AGENCY A DIAGNOSIS OF BIA-ALCL. THE PATIENT UNDERWENT AN ULTRASOUND WHICH OBSERVED A INTRA AND EXTRACAPSULAR RUPTURE OF THE DEVICE WITH SIGNIFICANT EFFUSION WITH "THICK PERIPROSTHETIC". A "PUNCTURE" OF THE EFFUSION WAS CARRIED OUT AND TESTED WHICH SHOWED "ABUNDANT PNN, ABSENCE OF ATYPICAL ELEMENT." THE DEVICE WAS REMOVED WITH TOTAL CAPSULECTOMY. A MASS WAS OBSERVED WITHIN THE CAPSULE OF 40MM. A SAMPLE OF THE CAPSULE WAS TESTED AND HISTOPATHOLOGICAL MARKERS CD30 + ALK- WERE CONFIRMED.

Description of Event or Problem · 0

PHYSICIAN REPORTED RIGHT SIDE VIA REGULATORY AGENCY A DIAGNOSIS OF BIA-ALCL. THE PATIENT UNDERWENT AN ULTRASOUND WHICH OBSERVED A INTRA AND EXTRACAPSULAR RUPTURE OF THE DEVICE WITH SIGNIFICANT EFFUSION WITH "THICK PERIPROSTHETIC". A "PUNCTURE" OF THE EFFUSION WAS CARRIED OUT AND TESTED WHICH SHOWED "ABUNDANT PNN, ABSENCE OF ATYPICAL ELEMENT." A MASS WAS OBSERVED WITHIN THE CAPSULE OF 40MM. A SAMPLE OF THE CAPSULE WAS TESTED AND HISTOPATHOLOGICAL MARKERS CD30 + ALK- WERE CONFIRMED. THE DEVICE HAS BEEN EXPLANTED. TREATMENT: TOTAL CAPSULECTOMY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1278896 STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED FTR ALLERGAN (COSTA RICA) 1364018 05060191601108

Patients

Seq Age Sex Outcome Treatment
1 67 YR Female Life Threatening| R